高视医疗 02407Stock Information

Stock Information · Old Rules
// Company Overview //
Stock Name高视医疗
Stock Code02407
Company Full Name高视医疗
Industry醫療保健
Principal Activities主要從事眼科醫療器械的研發、制造及銷售。
Listing Date2022-12-12
Listing Rules EraOld Rules
Listing Rules ChapterNo data
Weighted Voting Rights (WVR)No
Registered Address (Mainland China)中國北京市東城區東直門南大街11號中匯廣場A座1901室
Business Address (Hong Kong)No data
Place of IncorporationNo data
Listing MethodNo data
Listing BoardMain Board
Websitehttp://www.gaush.com/
Share Registrar卓佳证券登记有限公司 (Tricor Investor Services Limited)
Registrar Contact(852)2980 1333
A-Share/US Dual ListingNo data
// Offering Information //
Offering Mechanism 未知
Clawback TiersNo data
Prospectus Date2022-11-30
Offer PriceHK$ 51.40 / shares
Offer Price RangeFinal offer price only, no range
Lot Size100 shares
Entry ThresholdHK$ 5,140
Par ValueNo data
Global Offering Shares
HK Public Offering Shares— (0%)
International Placing Shares— (0%)
Offer RatioNo data
Total Shares Post-IPONo data
Total Global Offering SizeHK$ —
Public Offering SizeHK$ — (0%)
Oversubscription Multiple—x
Valid Applications
Accepted Applications
ReallocationNo
Total Funds RaisedHK$ 67,179,800
Greenshoe (Over-allotment Option)No data
// Valuation & Financials //
Market Cap (at Offer Price)HK$ 0
Pre-IPO Valuation (Last Round)No data
P/E Ratio-32.62
Profit/Loss StatusNo data
Period-End Cash BalanceNo data
Listing Expenses~HK$ 96,300,000
Listing Expenses / Funds RaisedNo data
Total Pre-IPO InvestmentNo data
// First Day Performance
First Day CloseLoading...
First Day OpenHK$ 51.2
First Day Change-90.47%
First Day Volume521800.0
First Day Turnover26102400.0
// Price Chart //
Loading...
// Use of Proceeds
Use of Proceeds1、約38.2%或108.1百萬港元將于上市后兩年內用于提高我們的研發能力及加速我們的專利商業化; 2、約29.0%或82.1百萬港元將于上市后兩年內用于提高我們的產能及增強我們的制造能力; 3、約9.5%或26.9百萬港元將于上市后兩年內用于透過聘請專門從事眼科醫療器械銷售及營銷的人員; 4、約10.6%或30.0百萬港元將用作我們的營運資金及一般企業用途; 5、約12.7%或36.0百萬港元將用于償還我們就收購泰靚所產生利率為5%的夾層融資貸款。
// Underwriting Syndicate //
联席保荐人 (2)
摩根士丹利亚洲有限公司 海通国际资本有限公司
整体协调人 (2)
摩根士丹利亚洲有限公司 海通国际证券有限公司
联席账簿管理人 (5)
摩根士丹利亚洲有限公司 海通国际证券有限公司 大和资本市场香港有限公司 富途证券国际(香港)有限公司 老虎证券(香港)环球有限公司
联席牵头经办人 (7)
摩根士丹利亚洲有限公司 海通国际证券有限公司 大和资本市场香港有限公司 富途证券国际(香港)有限公司 老虎证券(香港)环球有限公司 迈时资本有限公司 佳富达证券有限公司
// Cornerstone Investors //
#Investor NameInvestment AmountShares Subscribed% of Offer Shares% of Total SharesLock-up PeriodEst. Unlock Date
1 CL Kiwi Holding Ltd. 39,135,960 HKD 5.83% 6 months 2023-06-12
2 江苏中德服贸产业投资基金(有限合伙) 15,260,660 HKD 2.27% 6 months 2023-06-12
3 无锡高视创业投资合伙企业(有限合伙) 7,432,440 HKD 1.11% 6 months 2023-06-12
4 无锡视高股权投资合伙企业(有限合伙) 262,217,100 HKD 39.04% 6 months 2023-06-12
// Directors & Management //
Chairman高鐵塔
Company Secretary張博;梁瑞冰
No director data available.
// Major Shareholders //
Major Shareholders & Holdings高鐵塔(42.76%);Orbimed Asia Partners III, L.P.(12.19%);Cuprite Gem Investments Ltd(7.69%)
// Allotment Benchmarks //
Pool A (Small Subscriptions)
Shares AppliedApplicantsAllotteesExpected Lots
100 2,482 2,482 1.00
200 152 152 2.00
300 64 64 2.84
400 35 35 3.60
500 101 101 4.00
600 27 27 4.70
700 12 12 5.00
800 13 13 5.54
900 73 73 6.00
1,000 61 61 6.51
1,500 16 16 9.00
2,000 26 26 11.00
2,500 5 5 13.00
3,000 10 10 15.00
3,500 3 3 17.00
4,000 7 7 19.00
5,000 8 8 23.00
6,000 8 8 27.00
7,000 2 2 31.00
8,000 4 4 35.00
10,000 7 7 43.00
20,000 1 1 85.00
30,000 1 1 126.00
Pool B (Large Subscriptions)
Shares AppliedApplicantsAllotteesExpected Lots
100,000 1 1 624.00
150,000 1 1 934.95
200,000 4 4 1244.00
Allotment Benchmarks
Disclaimer & Risk Warning

Site Nature: This website (cibo.qizai.ai) is an independent technology product showcase platform established by Panda Securities Limited (CE Number: BNC380). This website itself and all content displayed herein do not constitute and are not involved in any regulated activity or licensed service.

Not Investment Advice: The data on this page is automatically extracted from prospectus PDFs by AI and may contain omissions or errors. Some data is supplemented from HKEX New Listing Reports ([HKEX]). All information and data on this page are sourced from prospectuses and related historical documents, are not real-time data, and will not be automatically updated, reflecting historical information at the time of prospectus publication. All content is provided solely for AI tool analysis learning exchange and technical reference purposes, and absolutely does not constitute any investment advice, offer to buy or sell, solicitation, recommendation, or guarantee. The output of this AI analysis tool should not be interpreted as investment opinion.

Decision Responsibility: Users should make investment decisions based on their own independent judgment and consult independent licensed financial advisors when needed. Neither the Company nor this AI analysis tool shall bear any responsibility for any investment decisions made by users based on the information on this page.

Separation from Panda Securities Official Website: The content of this website is strictly distinct from the SFC-regulated licensed services provided by Panda Securities' official website (fafa.hk). No securities trading or account opening or other regulated operations can be conducted through this website.

Panda Securities Limited is a licensed corporation regulated by the Hong Kong SFC (CE Number: BNC380) and a Hong Kong Exchange Participant (Participant ID: 02229). Use of this website constitutes acceptance of this disclaimer.

Cibo — IPO & Market Data Analytics